Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,704
Closed -$402K 38
2020
Q2
$402K Sell
1,704
-87,990
-98% -$20.1M 0.07% 28
2020
Q1
$18.2M Buy
+89,694
New +$19.6M 4.25% 17
2019
Q3
$520K Sell
2,685
-231
-8% -$44.3K 0.11% 28
2019
Q2
$537K Buy
2,916
+231
+9% +$41.4K 0.11% 27
2019
Q1
$510K Sell
2,685
-265
-9% -$50.6K 0.09% 30
2018
Q4
$574K Hold
2,950
0.11% 30
2018
Q3
$612K Hold
2,950
0.09% 31
2018
Q2
$545K Hold
2,950
0.08% 33
2018
Q1
$503K Hold
2,950
0.07% 32
2017
Q4
$513K Hold
2,950
0.07% 31
2017
Q3
$550K Hold
2,950
0.08% 32
2017
Q2
$508K Sell
2,950
-425
-13% -$69.1K 0.08% 33
2017
Q1
$554K Sell
3,375
-181,670
-98% -$30.2M 0.09% 29
2016
Q4
$27.1M Buy
185,045
+764
+0.4% +$115K 4.37% 17
2016
Q3
$30.7M Sell
184,281
-11,911
-6% -$2.01M 5.29% 6
2016
Q2
$29.9M Sell
196,192
-5,670
-3% -$882K 5.58% 8
2016
Q1
$30.3M Sell
201,862
-12,317
-6% -$1.83M 5.72% 5
2015
Q4
$34.8M Buy
+214,179
New +$33.7M 5.8% 1

Other funds holding AMGN

Darrell & King's AMGN Position: Q3 2020 in Review

Darrell & King sold out of Amgen (AMGN) in Q3 2020, closing a stake of 1,704 shares — an estimated $402K sold.

Darrell & King first reported a position in AMGN in Q4 2015 and held it in 18 quarters. The position peaked at $34.8M in Q4 2015. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Darrell & King reported no remaining Amgen position as of Q3 2020 after selling out during the quarter.
  • Darrell & King sold 1,704 Amgen shares in Q3 2020, an estimated $402K.
  • Darrell & King first reported a position in Amgen in Q4 2015 and held it in 18 quarters.
  • Darrell & King's Amgen position peaked at $34.8M in Q4 2015.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Darrell & King's 13F filing for Q3 2020, filed 16 Nov 2020.